In vitro
In vitro (meaning in glass, or in the glass)
Definition
In vitro (
In contrast, studies conducted in living beings (microorganisms, animals, humans, or whole plants) are called in vivo.[9]
Examples
Examples of in vitro studies include: the isolation, growth and identification of cells derived from
- Polymerase chain reaction is a method for selective replication of specific DNA and RNA sequences in the test tube.[16]
- Protein purification involves the isolation of a specific protein of interest from a complex mixture of proteins, often obtained from homogenized cells or tissues.[17]
- In vitro fertilization is used to allow spermatozoa to fertilize eggs in a culture dish before implanting the resulting embryo or embryos into the uterus of the prospective mother.[18]
- In vitro diagnostics refers to a wide range of medical and veterinary laboratory tests that are used to diagnose diseases and monitor the clinical status of patients using samples of blood, cells, or other tissues obtained from a patient.[19]
- In vitro testing has been used to characterize specific adsorption, distribution, metabolism, and excretion processes of drugs or general chemicals inside a living organism; for example, Caco-2 cell experiments can be performed to estimate the absorption of compounds through the lining of the gastrointestinal tract;PBPK.
Advantages
In vitro studies permit a species-specific, simpler, more convenient, and more detailed analysis than can be done with the whole organism. Just as studies in whole animals more and more replace human trials, so are in vitro studies replacing studies in whole animals.
Simplicity
Living organisms are extremely complex functional systems that are made up of, at a minimum, many tens of thousands of genes, protein molecules, RNA molecules, small organic compounds, inorganic ions, and complexes in an environment that is spatially organized by membranes, and in the case of multicellular organisms, organ systems.[23][24] These myriad components interact with each other and with their environment in a way that processes food, removes waste, moves components to the correct location, and is responsive to signalling molecules, other organisms, light, sound, heat, taste, touch, and balance.
This complexity makes it difficult to identify the interactions between individual components and to explore their basic biological functions. In vitro work simplifies the system under study, so the investigator can focus on a small number of components.[25][26]
For example, the identity of proteins of the immune system (e.g. antibodies), and the mechanism by which they recognize and bind to foreign antigens would remain very obscure if not for the extensive use of in vitro work to isolate the proteins, identify the cells and genes that produce them, study the physical properties of their interaction with antigens, and identify how those interactions lead to cellular signals that activate other components of the immune system.
Species specificity
Another advantage of in vitro methods is that human cells can be studied without "extrapolation" from an experimental animal's cellular response.[27][28][29]
Convenience, automation
In vitro methods can be miniaturized and automated, yielding high-throughput screening methods for testing molecules in pharmacology or toxicology.[30]
Disadvantages
The primary disadvantage of in vitro experimental studies is that it may be challenging to extrapolate from the results of in vitro work back to the biology of the intact organism. Investigators doing in vitro work must be careful to avoid over-interpretation of their results, which can lead to erroneous conclusions about organismal and systems biology.[31][32]
For example, scientists developing a new viral drug to treat an infection with a pathogenic virus (e.g., HIV-1) may find that a candidate drug functions to prevent viral replication in an in vitro setting (typically cell culture). However, before this drug is used in the clinic, it must progress through a series of in vivo trials to determine if it is safe and effective in intact organisms (typically small animals, primates, and humans in succession). Typically, most candidate drugs that are effective in vitro prove to be ineffective in vivo because of issues associated with delivery of the drug to the affected tissues, toxicity towards essential parts of the organism that were not represented in the initial in vitro studies, or other issues.[33]
In vitro test batteries
A method which could help decrease animal testing is the use of in vitro batteries, where several in vitro assays are compiled to cover multiple endpoints. Within developmental neurotoxicity and reproductive toxicity there are hopes for test batteries to become easy screening methods for prioritization for which chemicals to be risk assessed and in which order.[34][35][36][37] Within ecotoxicology in vitro test batteries are already in use for regulatory purpose and for toxicological evaluation of chemicals.[38] In vitro tests can also be combined with in vivo testing to make a in vitro in vivo test battery, for example for pharmaceutical testing.[39]
In vitro to in vivo extrapolation
Results obtained from in vitro experiments cannot usually be transposed, as is, to predict the reaction of an entire organism in vivo. Building a consistent and reliable extrapolation procedure from in vitro results to in vivo is therefore extremely important. Solutions include:
- Increasing the complexity of in vitro systems to reproduce tissues and interactions between them (as in "human on chip" systems)[40]
- Using mathematical modeling to numerically simulate the behavior of the complex system, where the in vitro data provide model parameter values[41]
These two approaches are not incompatible; better in vitro systems provide better data to mathematical models. However, increasingly sophisticated in vitro experiments collect increasingly numerous, complex, and challenging data to integrate. Mathematical models, such as systems biology models, are much needed here.[42]
Extrapolating in pharmacology
In pharmacology, IVIVE can be used to approximate pharmacokinetics (PK) or pharmacodynamics (PD).[citation needed] Since the timing and intensity of effects on a given target depend on the concentration time course of candidate drug (parent molecule or metabolites) at that target site, in vivo tissue and organ sensitivities can be completely different or even inverse of those observed on cells cultured and exposed in vitro. That indicates that extrapolating effects observed in vitro needs a quantitative model of in vivo PK. Physiologically based PK (
In the case of early effects or those without intercellular communications, the same cellular exposure concentration is assumed to cause the same effects, both qualitatively and quantitatively, in vitro and in vivo. In these conditions, developing a simple PD model of the dose–response relationship observed in vitro, and transposing it without changes to predict in vivo effects is not enough.[44]
See also
- Animal testing
- Ex vivo
- In situ
- In utero
- In vivo
- In silico
- In papyro
- In natura
- Animal in vitro cellular and developmental biology
- Plant in vitro cellular and developmental biology
- In vitro toxicology
- In vitro to in vivo extrapolation
- Slice preparation
References
- ^ "In vitro methods - ECHA". echa.europa.eu. Retrieved 2023-04-11.
- ^ Toxicity, National Research Council (US) Subcommittee on Reproductive and Developmental (2001). Experimental Animal and In Vitro Study Designs. National Academies Press (US).
- ^ Merriam-Webster, Merriam-Webster's Collegiate Dictionary, Merriam-Webster, archived from the original on 2020-10-10, retrieved 2014-04-20.
- ISBN 978-0-19-517633-9.
- ISBN 978-1-4338-0562-2.
- ^ "In vitro methods - ECHA". echa.europa.eu. Retrieved 2023-04-11.
- ^ Toxicity, National Research Council (US) Subcommittee on Reproductive and Developmental (2001). Experimental Animal and In Vitro Study Designs. National Academies Press (US).
- ^ "Omics technologies in chemical testing - OECD". www.oecd.org. Retrieved 2023-04-11.
- ^ Toxicity, National Research Council (US) Subcommittee on Reproductive and Developmental (2001). Experimental Animal and In Vitro Study Designs. National Academies Press (US).
- ISBN 978-0-12-473270-4, retrieved 2023-04-11
- PMID 29229998.
- PMID 32111839.
- PMID 33995902.
- PMID 30151583, retrieved 2023-04-11
- PMID 33514944.
- ^ "Polymerase chain reaction (PCR) (article)". Khan Academy. Retrieved 2023-04-11.
- PMID 24648062, retrieved 2023-04-11
- ISBN 978-0-08-096156-9, retrieved 2023-04-11
- ^ "In vitro diagnostics - Global". www.who.int. Retrieved 2023-04-11.
- ^
Artursson P.; Palm K.; Luthman K. (2001). "Caco-2 monolayers in experimental and theoretical predictions of drug transport". Advanced Drug Delivery Reviews. 46 (1–3): 27–43. PMID 11259831.
- ^
Gargas M.L.; Burgess R.L.; Voisard D.E.; Cason G.H.; Andersen M.E. (1989). "Partition-Coefficients of low-molecular-weight volatile chemicals in various liquids and tissues". Toxicology and Applied Pharmacology. 98 (1): 87–99. S2CID 6928235.
- ^
Pelkonen O.; Turpeinen M. (2007). "In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations". Xenobiotica. 37 (10–11): 1066–1089. S2CID 3043750.
- ISBN 978-0-8153-4105-5.
- ^ "Biological Complexity and Integrative Levels of Organization | Learn Science at Scitable". www.nature.com. Retrieved 2023-04-11.
- ISBN 978-90-481-3766-4.
- ISBN 978-0-19-920570-7.
- ^ "Existing Non-animal Alternatives". AltTox.org. 20 November 2016. Archived from the original on March 13, 2020.
- PMID 30404629.
- S2CID 237944066.
- ^ Quignot N.; Hamon J.; Bois F. (2014). Extrapolating in vitro results to predict human toxicity, in In Vitro Toxicology Systems, Bal-Price A., Jennings P., Eds, Methods in Pharmacology and Toxicology series. New York, US: Springer Science. pp. 531–550.
- ISBN 0-07-137820-0.
- ISBN 978-0-12-473270-4, retrieved 2023-04-11
- PMID 16125443.
- PMID 36328314.
- ^ OECD (2023-04-14). "OECD work on in vitro assays for developmental neurotoxicity". Retrieved 2023-07-04.
- PMID 23511061.
- S2CID 251187782.
- ISBN 978-94-007-5704-2, retrieved 2023-07-04
- ^ European Medicines Agency (EMA) (2013-02-11). "ICH S2 (R1) Genotoxicity testing and data interpretation for pharmaceuticals intended for human use - Scientific guideline" (PDF). European Medicines Agency - Science Medicines Health.
- S2CID 30583735.
- ^
Quignot, Nadia; Bois, Frédéric Yves (2013). "A computational model to predict rat ovarian steroid secretion from in vitro experiments with endocrine disruptors". PLOS ONE. 8 (1): e53891. PMID 23326527.
- S2CID 232122825.
- S2CID 3083574.
- PMID 20833708.
External links
- Media related to In vitro at Wikimedia Commons